Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study
Clinical trial NCT05294289 · COMPLETED
Trial details
- NCT number
- NCT05294289
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-16
- Primary completion
- 2024-06-28
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.